Table 2.
Baseline, treatment agents during hospitalization and outcome of TIA patients with positive and negative DWI.
| DWI positive (N = 279) | DWI negative (N = 382) | p Value | |
|---|---|---|---|
| Age | 56.94 ± 12.93 | 57.65 ± 12.05 | 0.472 |
| Female | 104 (37.3%) | 150 (39.3%) | 0.603 |
| HTN | 163 (58.4%) | 206 (53.9%) | 0.250 |
| Hyperlipidemia | 53 (19.0%) | 73 (19.1%) | 0.971 |
| DM | 45 (16.1%) | 63 (16.5%) | 0.901 |
| Previous stroke | 60 (21.5%) | 74 (19.4%) | 0.500 |
| CHD | 22 (7.9%) | 50 (13.1%) | 0.034 |
| Current smoker | 75 (26.9%) | 97 (25.4%) | 0.667 |
| ABCD2 score ≥ 4 | 138 (49.5%) | 141 (36.9%) | 0.001 |
| LAA | 125 (44.8%) | 101 (26.4%) | < 0.001 |
| Treatment agents during hospitalization | |||
| Statins therapy | 258 (92.5%) | 353 (92.4%) | 0.975 |
| Antihypertension | 103 (38.6%) | 126 (34.0%) | 0.231 |
| Hypoglycemic agent | 55 (20.6%) | 58 (15.6%) | 0.105 |
| DAPT | 127 (45.5%) | 154 (40.3%) | 0.181 |
| 90-day stroke | 53 (19.0%) | 17 (4.5%) | < 0.001 |
DAPT, dual antiplatelet therapy; DWI, diffusion-weighted image; HTN, hypertension; DM, diabetes mellitus; CHD, coronary heart disease; LAA, large-artery atherosclerosis; p value shows the differences between DWI positive and negative TIA patients.